About Sterkem Pharma Private Limited
Data last updated:
Sterkem Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2002PTC135324. Its GSTIN is 27AAGCS2781K1ZX (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Heena Mayank Patel and Ajit Naginbhai Desai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.83 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹9.28 Lakh (net margin -0.7%) and EBITDA of ₹5,799 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company has about 119 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Ster Chem and Sterkem Pharma. As per MCA filings, the company has open charges of ₹11 Lakh on record. Court records list 18 cases involving the company, including 13 filed by the company and 5 filed against it; 11 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sterkempharma.com.
Company details
Contact details
Sterkem Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is sterkempharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS/3 Khira Indl Estate B M Bhargoankar Road, Santacruz West, Mumbai, Maharashtra, India – 400054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sterkem Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sterkem Pharma operates two associated brands: Ster Chem and Sterkem Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ster Chem is a CDMO specializing in the manufacturing of active pharmaceutical ingredients. | sterchem.com | |
| Pharmaceutical marketing of anti-arthritic drugs, analgesics, and nutritional supplements in healthcare. | sterkempharma.com |
Business activity
The main business activity of Sterkem Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sterkem Pharma Private Limited, buy the company report.
Financials of Sterkem Pharma Private Limited
FY 2025 filings availableSterkem Pharma Private Limited reported revenue of ₹12.83 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 2% growth in the latest year. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,799 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sterkem Pharma Private Limited, buy the company report.
Board of directors of Sterkem Pharma Private Limited
Sterkem Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Heena Mayank Patel Also directs: E M Pharmaceuticals Private Limited | Director | 01 Apr 2015 | 11 Years 6 Months | Current |
| Ajit Naginbhai Desai Also directs: E M Pharmaceuticals Private Limited | Director | 28 Mar 2002 | 24 Years 6 Months | Current |
| Sheela Harish Merchant | Director | 01 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Sterkem Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Calren Care Lifesciences Private Limited | ₹12.87 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| Sindhuja Hydrocarbons Private Limited | ₹12.84 Cr (FY 2024) | 142.0% | Ahmedabad, Gujarat, India | |||
| Sterkem Pharma Private Limitedthis company | ₹12.83 Cr (FY 2025) | -₹9.28 Lakh | -0.7% | 2.0% | 119 | Mumbai, Maharashtra, India |
| Three Dots Life Science Private Limited | ₹12.83 Cr (FY 2025) | 21.0% | Patna, Bihar, India | |||
| Regoshin Healthcare Private Limited | ₹12.81 Cr (FY 2024) | 25.0% | New Delhi, Delhi, India | |||
| Uniwend Medicals Pvt Ltd | ₹12.81 Cr (FY 2025) | -7.0% | Quilon, Kerala, India | |||
| Integrity Formulations Private Limited | ₹12.8 Cr (FY 2025) | -34.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Sterkem Pharma Private Limited, buy the company report.
Auditor
Sterkem Pharma Private Limited is audited by SANJAY M. DESAI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY M. DESAI & CO | FY 2022 | 031092 |
Shareholding
The shareholding of Sterkem Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sterkem Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2023 | 100862315 | Hdfc Bank Limited | ₹11 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Sterkem Pharma Private Limited has 18 court cases on record: 13 filed by Sterkem Pharma, 5 filed against it. 11 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 2 | 9 |
| High courts | 4 | 3 | 2 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Biomax Biotechnics Pvt Ltd | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Taksa Lifescience Pvt Ltd | Pending |
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed by the company against Elfin Drugs Pvt Ltd and Ors | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Alaric Life Sciences Pvt Ltd | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Dipna Pharmachem Limited and Ors | Pending |
To see the full case history of Sterkem Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sterkem Pharma Private Limited has 2 MSME Form 1 returns on record between 2021 and 2022, listing 150 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Primus Pharmaceuticals | |||
| Integrated Laboratories Private Limited | |||
| Sayora Pharma Private Limited | |||
| an individual supplier | |||
| Knox Life Science |
To see the full MSME payment records of Sterkem Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sterkem Pharma Private Limited has a workforce of 119 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Sterkem Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCS2781K1ZX | Maharashtra | Active | 01 Jul 2017 |
| 24AAGCS2781K1Z3 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sterkem Pharma Private Limited, buy the company report.
Recent activity
Sterkem Pharma Private Limited has 6 board changes on record since 2002: 3 appointments and 3 cessations. The latest: Sheela Harish Merchant was appointed as Director on 01 Sep 2025.
Frequently asked questions
Sterkem Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2002 (24+ years old) and is registered under CIN U51909MH2002PTC135324.
Sterkem Pharma has 3 current directors:
- Heena Mayank Patel - Director
- Ajit Naginbhai Desai - Director
- Sheela Harish Merchant - Director
The latest financial statements of Sterkem Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sterkem Pharma is 27AAGCS2781K1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAGCS2781K1Z3 (Gujarat).
The CIN (Corporate Identification Number) of Sterkem Pharma is U51909MH2002PTC135324. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sterkem Pharma has 18 court cases on record: 13 filed by the company and 5 filed against it. 11 are pending. Most are in the district courts.
Sterkem Pharma was incorporated on 28 March 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sterkem Pharma by revenue are Calren Care Lifesciences Private Limited, Sindhuja Hydrocarbons Private Limited, Three Dots Life Science Private Limited, Regoshin Healthcare Private Limited, Uniwend Medicals Pvt Ltd and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sheela Harish Merchant was appointed as Director on 01 Sep 2025. Jayantilal Lallubhai Patel ceased to be Director on 01 Jul 2015. Heena Mayank Patel was appointed as Director on 01 Apr 2015. Sterkem Pharma has 6 board changes on record in total.
Sterkem Pharma has 2 MSME Form 1 returns on record between 2021 and 2022, listing 150 overdue payments to 7 micro and small suppliers. The latest return was filed on 09 May 2022.
Sterkem Pharma can be reached through the website sterkempharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sterkem Pharma is at S3 Khira Indl Estate B M Bhargoankar Road, Santacruz West, Mumbai, Maharashtra, India – 400054.